Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Arecor Therapeutics PLC
Telephone
44.1223.426.060
Address
Chesterford Research Park, Little Chesterford, Essex CB10 1XL
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.4 - 1
Trade Value (12mth)
US$7,987.00
1 week
0%
1 month
0%
YTD
-22.35%
1 year
57.14%
All time high
4.72
EPS 3 yr Growth
-105.50%
EBITDA Margin
-259.70%
Operating Cashflow
-£2m
Free Cash Flow Return
-38.40%
ROIC
15.60%
Interest Coverage
-404.60
Quick Ratio
4.30
Shares Outstanding (Fully Diluted)
38m
HALO Sector
Healthcare
Next Company Report Date
27-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.00
| Date | Announcements |
| 18 May 26 | |
| 29 April 26 | |
| 13 April 26 | |
| 30 March 26 | |
| 26 March 26 |
Historical data
Forecast data
| GBP | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | £ |  | | | | -0.28 | -0.31 | 0.02 | | | | ||
EPS (Fully Diluted) | £ | | | | | -0.28 | -0.31 | 0.02 | | | | ||
Growth | % | | | | | 12.7 | -9.6 | 105.7 | | | | ||
PE | X | | | | | N/A | N/A | 45.7 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
